Global Trends and Growth Forecast in the Assisted Reproductive Technology Market
The Assisted Reproductive Technology (ART) Market plays a pivotal role in addressing infertility by offering a range of advanced medical techniques designed to facilitate conception. This market encompasses in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and various other procedures that assist in fertilization outside the human body. Key components include fertility drugs, sperm and egg retrieval procedures, embryo culture, and implantation techniques. The market is driven by the increasing prevalence of infertility, changing lifestyles, and advancements in reproductive medicine.
Major
drivers of the Assisted Reproductive Technology Market include growing awareness,
expanding acceptance of non-traditional family structures, and improvements in
success rates through technological innovations. The integration of
technologies such as pre-implantation genetic testing and cryopreservation has
significantly enhanced the efficiency and outcomes of ART procedures.
Challenges
involve the high cost of ART procedures, ethical considerations, and varying
regulations across regions. Geographically, North America and Europe lead in
market share due to well-established healthcare infrastructures, while
Asia-Pacific is experiencing rapid growth with a rising demand for fertility
treatments. As the Assisted Reproductive Technology Market continues to evolve,
it remains a cornerstone in addressing the complexities of infertility and providing
hope to individuals and couples seeking to build their families.
Assisted reproductive technology (ART) market is gaining
precedence owing to its ability to cure women having infertility issues. The
assisted reproductive technology industry includes fertility medication, in
vitro fertilization and surrogacy. The global assisted reproductive technology
market
can experience a 9.8% CAGR during the forecast period (2023-2032), reveals
Market Research Future (MRFR) in a report that covers drivers of the said
market and segments in detail. Infertility cases are on the rise, that too, at
an alarming rate. This has been triggered by a sedentary lifestyle, obesity, ovulation disorder, unhealthy diet,
increasing intake of tobacco & alcohol, and chronic diseases.
However, lower success rate, high
cost, chances of birth defects, and side
effects associated with hysterectomy procedures are some issues that can pose
hurdles to stop the regular market growth
during the forecast period.
Competitive Landscape:
Some of the key players in the global assisted reproductive technology market
companies
are Anecova, Origio, California Cryobank, Cosmos Biomedical Limited, Cryolab
Ltd., Parallabs, OvaScience, Microm Ltd., Merck KGaA, Cooper Surgical, Inc,
Bloom IVF Centre, Ferring Pharmaceuticals, European Sperm Bank, Irvine
Scientific and Hamilton Throne Ltd.
Segmentation:
The global assisted reproductive
technology (ART) market can be segmented
by diagnosis, type, end-user.
By diagnosis, the assisted
reproductive technology market can be segmented
into ovulation testing, hysterosalpingography, ovarian reserve testing, genetic
testing, other hormone testing, and imaging tests.
Based on type, the assisted reproductive technology market includes
Ovulation Induction (OI), Artificial Insemination (AI), Donor Conception,
In-Vitro Fertilization (IVF), Gamete Intrafallopian Transfer (GIFT),
Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Diagnosis
(PGD) and Surrogacy.
Based on end-user, the assisted
reproductive technology market can be segmented
into hospitals and clinics, ambulatory surgical centers, diagnostic centers,
gynecology centers, feminist health centers, and IVF centers and others.
Regional
Analysis:
Region-specific analysis of the
assisted reproductive technology market includes Europe, the Americas, Asia
Pacific (APAC), and Middle East & Africa (MEA).
Europe, at present, is dominating the
market as the region is gaining substantially from increasing innovations in
clinical practice and access to fertility treatment in this region.
Infrastructural standard related to the healthcare
sector can also be touted as influencers.
The Americas is assuming the second
spot, and the market scenario is going to
remain the same during the forecast period. Increasing cases of cancer can be seen as a potential
market booster. The APAC market is projected to become the fastest growing
segment during the forecast period. Rising cases of, obesity and diabetes can
be taken into consideration while judging the parameters of the regional
growth. The MEA market is expected to generate the least amount of share owing
to stringent government policies and low per capita income.
Market
Insight:
Merger, acquisition, collaboration,
partnership, and other methods are some tactical moves that the companies
employ to sustain and grow. This, as a
consequence, also helps the market in its growth. For instance, California
Cryobank and Cord Blood Registry have entered into a definitive agreement that
will work as a new entity under California Cryobank Life Sciences platform to
bring in the best of domestic and international opportunities for expansion and
better the research & development sector of donor reproductive tissue and newborn stem cell industries.
Related Report:
Medicated Personal
Care Products
For more information
visit at MarketResearchFuture
Comments
Post a Comment